Enteric Empty Capsules Industry

The global enteric empty capsules market size was estimated at USD 2.96 billion in 2023 and is projected to grow at a CAGR of 6.54% from 2024 to 2030. The growth of the market is driven by an increasing demand for pharmaceutical products, growing adoption of enteric capsules by pharmaceutical companies, rising prevalence of gastrointestinal disorders, and technological advancements in capsule manufacturing.

The pharmaceutical industry’s growth is a significant driver of the enteric empty capsules market. With the increasing global population and rising healthcare awareness, there is a growing demand for pharmaceutical products worldwide. They are widely used for encapsulating various drugs, especially those sensitive to gastric acid.In May 2021, Evonik launched EUDRACAP, a commercial-scale functional capsule for fast and effective drug development. EUDRACAP, based on oral drug delivery technology, accommodates sensitive molecules, including biologicals, from early development to commercial scaling.

Pharmaceutical companies are increasingly opting for enteric capsules due to their ability to protect drugs from degradation in the acidic environment of the stomach. This trend is driving the demand for enteric empty capsules in the market.In a March 2024 study from Nutrients, researchers found that an enteric-coated tablet formulation enables sodium bicarbonate protection in acidic conditions and its release in the intestine. This approach reduces the required dose to reach a blood bicarbonate level over 5 mmol∙L−1 from 300 mg∙kg−1 to 225 mg∙kg−1, cutting the dose by 25% and lessening gastrointestinal discomfort.

Gather more insights about the market drivers, restrains and growth of the Global Enteric Empty Capsules market

The increasing prevalence of gastrointestinal disorders such as acid reflux, ulcers, and inflammatory bowel diseases is fueling the demand for enteric empty capsules. Patients with these conditions often require medications that can bypass the stomach and release their contents in the intestines. This has led to a higher utilization in drug delivery systems.In a May 2024 publication in Molecular Pharmaceutics, researchers presented enteric-coated capsules designed for precise drug delivery to the distal ileum, effectively targeting the area richest in Peyer’s patches.

Global Enteric Empty Capsules Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global enteric empty capsules market report based on product, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
    • Gelatin Capsules
    • Hydroxypropyl Methylcellulose (HPMC) Capsules
    • Vegetable Capsules
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
    • Antacid and Antiflatulent Preparations
    • Antibiotic and Antibacterial Drugs
    • Others
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
    • Pharmaceutical Manufacturers
    • Nutraceutical Manufacturers
    • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • Denmark
      • Sweden
      • Norway
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Thailand
    • Latin America
      • Brazil
      • Argentina
    • MEA
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait

Key Enteric Empty Capsules Company Insights

Key players operating in the market are undertaking various initiatives to strengthen their market presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are playing a key role in propelling the market growth.

Key Enteric Empty Capsules Companies:

The following are the leading companies in the enteric empty capsules market. These companies collectively hold the largest market share and dictate industry trends.

  • Lonza
  • Roquette Frères
  • SUHEUNG
  • Farmacápsulas
  • Nectar Lifesciences Ltd.
  • ZHEJIANG HUILI CAPSULES CO., LTD
  • Shaoxing Zhongya Capsule Co., Ltd.
  • Chemcaps Limited
  • Fortcaps
  • Natural Capsules Limited

Recent Developments

  • In June 2024, Lonza Group Ltd. introduced the Capsugel Enprotect. This innovation features a size 9 capsule designed for drug protection against stomach acid, ensuring enteric release. Targeted primarily at pre-clinical rodent testing, this development aims to fast-track the drug evaluation process.
  • In December 2023, the World Economic Forum included ACG Worldwide's capsule manufacturing facility in Pithampur, India in its Global Lighthouse Network. This network recognizes entities employing advanced technologies to significantly transform their operations and business models. ACG Worldwide serves as a supplier and service provider to the pharmaceutical sector.
  • In October 2023, Evonik unveiled a new EUDRACAP functional oral capsule for preclinical studies, adding a globally available size 9h enteric-coated capsule to its range. This enhances the EUDRACAP platform, easing the shift from preclinical to first-in-human studies and lowering drug developers' risks and complexities.

Order a free sample PDF of the Enteric Empty Capsules Market Intelligence Study, published by Grand View Research.